Drug Eluting Stent Registry of Thrombosis
DESERT
1 other identifier
observational
984
3 countries
20
Brief Summary
Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2009
Typical duration for all trials
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2008
CompletedFirst Posted
Study publicly available on registry
December 22, 2008
CompletedStudy Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedApril 23, 2013
April 1, 2013
2.7 years
December 18, 2008
April 22, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
To assess for potential correlates surrounding subjects and lesions among patients that experience late or very late drug-eluting stent thrombosis
Baseline
Study Arms (2)
Case
Late or very late drug-eluting stent thrombosis
Control
No drug-eluting stent thrombosis
Eligibility Criteria
Patients, male or female, over 18 years of age, who are either known to have experienced late or very late drug-eluting stent thrombosis (Case), or have undergone drug-eluting stent implantation at the same facility, in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis (Control).
You may qualify if:
- Patients over 18 years of age
- Case Subjects: patients who have experienced definite late or very late drug-eluting stent thrombosis
- Control Subjects: patients who underwent drug-eluting stent implantation at the same facility and in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (20)
Mercy General Hospital / Mercy Heart and Vascular Institute Cardiovascular Research
Sacramento, California, 95819, United States
Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Prairie Education and Research Cooperative
Springfield, Illinois, 62701, United States
Lexington Cardiac Research Foundation/Central Baptist Hospital
Lexington, Kentucky, 40503, United States
Maine Medical Center
Portland, Maine, 04102, United States
Washington Adventist Hospital
Takoma Park, Maryland, 20912, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Lahey Clinic
Burlington, Massachusetts, 01805, United States
Saint Luke's Hospital, Mid America Heart Institute
Kansas City, Missouri, 64111, United States
The Valley Hospital
Ridgewood, New Jersey, 07450, United States
New York Methodist Hospital
Brooklyn, New York, 11215, United States
Columbia University Medical Center
New York, New York, 10032, United States
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, 27157, United States
Summa Health System
Akron, Ohio, 44309, United States
Geisinger Health System
Danville, Pennsylvania, 17822, United States
The Miriam Hospital
Providence, Rhode Island, 02906, United States
South Carolina Heart Center, PA
Columbia, South Carolina, 29204, United States
Winchester Medical Center
Winchester, Virginia, 22601, United States
Laval Hospital
Québec, Quebec, G1V4G5, Canada
Bern University Hospital
Bern, 3010, Switzerland
Related Publications (1)
Waksman R, Kirtane AJ, Torguson R, Cohen DJ, Ryan T, Raber L, Applegate R, Waxman S, Gordon P, Kaneshige K, Leon MB; DESERT Investigators. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis). JACC Cardiovasc Interv. 2014 Oct;7(10):1093-102. doi: 10.1016/j.jcin.2014.04.017. Epub 2014 Sep 17.
PMID: 25240540DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2008
First Posted
December 22, 2008
Study Start
September 1, 2009
Primary Completion
May 1, 2012
Study Completion
May 1, 2012
Last Updated
April 23, 2013
Record last verified: 2013-04